Sun Life Financial’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Sun Life Financial’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-750	Closed	-$40K	–	498
2017 Q4	$40K	Hold	750	–	–	﹤0.01%	303
2017 Q3	$43K	Hold	750	–	–	﹤0.01%	466
2017 Q2	$45K	Buy	750 +709	+1,729%	+$40.4K	﹤0.01%	461
2017 Q1	$750	Buy	+41	New	+$2.02K	﹤0.01%	147

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Sun Life Financial's BIVV Position: Q1 2018 in Review

Sun Life Financial sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 750 shares — an estimated $40K sold.

Sun Life Financial first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $45K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Sun Life Financial reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Sun Life Financial sold 750 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $40K.
Sun Life Financial first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Sun Life Financial's Bioverativ Inc. Common Stock position peaked at $45K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Sun Life Financial's 13F filing for Q1 2018, filed 14 May 2018.